Table 3 Results of the NUT study.
From: Antithrombotic prevention in vascular disease: bases for a new strategy in antithrombotic therapy
Events (%) at 3-month Follow-up | RR (%) | AR (%) | NNT |
|---|---|---|---|
Patients (n) | 60 | 60 | Â |
Recurrent angina + MI | 58.6 | 28.3 | 3.5 |
Revascularization (PTCA and CABG) | 61.0 | 18.3 | 5.5 |
Recurrent angina + MI + mortality | 55.2 | 26.3 | 3.8 |
MI + revascularization + mortality | 60.1 | 20 | 5.0 |